Enhancement of dissolution amount and in vivo bioavailability of itraconazole by complexation with β-cyclodextrin using supercritical carbon dioxide

Journal of Pharmaceutical and Biomedical Analysis

Volumn 45, Issue 2, 2007, Pages 243-250

  Hassan, Hazem A ^a   Al Marzouqi, Ali H ^a   Jobe, Baboucarr ^a   Hamza, Alaa A ^a   Ramadan, Gaber A ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cyclodextrin; Bioavailability; Dissolution; Inclusion complex; Itraconazole; Supercritical carbon dioxide

Indexed keywords

BETA CYCLODEXTRIN; CARBON DIOXIDE; ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG SOLUBILITY; INTERMETHOD COMPARISON; KIDNEY; MALE; NONHUMAN; PRECIPITATION; PRESSURE; PRIORITY JOURNAL; RAT; STOMACH JUICE; TEMPERATURE;

ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CARBON DIOXIDE; CHROMATOGRAPHY, SUPERCRITICAL FLUID; DRUG COMPOUNDING; EXCIPIENTS; GASTRIC JUICE; ITRACONAZOLE; MALE; PRECIPITATION; PRESSURE; RATS; RATS, WISTAR; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TEMPERATURE; TISSUE DISTRIBUTION;

EID: 34848845290     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.06.011     Document Type: Article

References (34)

1. Van Cutsem J., Van Gerven F., Van de Ven M.A., Borger M., and Janssen P.A.J. Antimicrob. Agents Chemother. 26 (1984) 527-534
2. Hay R.J., Dupont B., and Graybill J.R. Rev. Infect. Dis. 9 (1987) S1-S3
3. Hostetler J.S., Hanson L.H., and Stevens D.A. Antimicrob. Agents Chemother. 36 (1992) 477-480
4. Heykants J., Michiels M., Meuldermans W., Monbaliu J., Lavrijsen K., Van Peer A., Levron J.C., Woestenborghs R., and Cauwenbergh G. In: Fromtling M.A. (Ed). Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (1987), JR Prous Science Publishers, Barcelona 223-249
5. Huang Y.C., Colaizzi J.L., Bierman R.H., Woestenborghs R., and Heykants J. Antimicrob. Agents Chemother. 30 (1986) 206-210
6. Wishart J.M. J. Am. Acad. Dermatol. 17 (1987) 220-223
7. Blum R.A., D'Andrea D.T., Florentino B.M., Wilton J.H., Hilligoss D.M., Gardner M.J., Henry E.B., Goldstein H., and Schentag J.J. Ann. Intern. Med. 114 (1991) 754-757
8. Denning D.W., Tucker R.M., Hanson L.H., and Stevens D.A. Am. J. Med. 86 (1989) 791-800
9. Strickley R. Pharm. Res. 21 (2004) 201-230
10. Ahmed M., El-Gibaly I., and Ahmed S. Int. J. Pharm. 171 (1998) 111-121
11. Duchene D., and Wouessidjewe D. Drug Dev. Ind. Pharm. 16 (1990) 2487-2499
12. Fernandes C., Vieira M., and Veiga F. Eur. J. Pharm. Sci. 15 (2002) 79-88
13. Greczy J., Bruhwyler J., Scuvee-Moreau J., Seutin V., Masset H., Van Heugen J., Dresse A., Lejeune C., Decamp E., Szente L., Szejtli J., and Liegeois J. Psychopharmacology 151 (2000) 328-334
14. Kang J., Kumar V., Yang D., Chowdhury P., and Hohl R. Eur. J. Pharm. Sci. 15 (2002) 163-170
15. Lee B., and Lee J. Arch. Pharm. Res. 18 (1995) 22-26
16. Mura P., Adragna E., Rabasco A., Moyano J., Perez-Martinez J., Arias M., and Gines J. Drug Dev. Ind. Pharm. 25 (1999) 279-287
17. Nagarsenker M., Meshram R., and Ramprakash G. J. Pharm. Pharmacol. 52 (2000) 949-956
18. Szejtli J. Cyclodextrins in Pharmacy (1994), Dordrecht, Kluwer, The Netherlands
19. Loftsson T., Masson M., and Brewster M. J. Pharm. Sci. 93 (2004) 1091-1099
20. Peeters J., Neeskens P., Tollenaere J., Remoortere P., and Brewstrer M. J. Pharm. Sci. 91 (2002) 1414-1422
21. Van Hees T., Piel G., Evrard B., Otte X., Thunus L., and Delattre L. Pharm. Res. 16 (1999) 1864-1870
22. Van Hees T., Barillaro V., Piel G., Bertholet P., De Hassonville S., Evrard B., and Delattre L. J. Incl. Phenom. Macrocycl. Chem. 44 (2002) 271-274
23. Charoenchaitrakool M., Dehghani F., and Foster N.R. Int. J. Pharm. 239 (2002) 103-112
24. Türk M., Upper G., Steurenthaler M., Hussein Kh., and Wahl M.A. J. Supercrit. Fluids 39 (2007) 435-443
25. Bandi N., Wei W., Roberts C.B., Kotra L.P., and Kompella U.B. Eur. J. Pharm. Sci. 23 (2004) 159-168
26. I. Fabing, F. Leboeuf, J. Jung, M. Perrut, Patents FR 2 815 540-WO 0232462-EP 1, 330, 266 (2000).
27. Perrut M., Jung J., and Leboeuf F. Int. J. Pharm. 288 (2005) 11-16
28. Rodier E., Lochard H., Sauceau M., Letourneau J.-J., Freiss B., and Fages J. Eur. J. Pharm. Sci. 26 (2005) 184-193
29. Al-Marzouqi A.H., Shehatta I., Jobe B., and Dowaidar A. J. Pharm. Sci. 95 (2006) 292-304
30. Shehatta I., Al-Marzouqi A.H., Jobe B., and Dowaidar A. Can. J. Chem. 83 (2005) 1833-1838
31. Al-Marzouqi A.H., Jobe B., Dowaidar A., Maestrelli F., and Mura P. J. Pharm. Biomed. Anal. 43 (2007) 566-574
32. Hassan A., Tang Y., and Ayres J. Drug Dev. Ind. Pharm. 30 (2004) 1029-1035
33. Paget G.E., and Thomson R. Standard Operating Procedures in Toxicology (1979), MTP Press Limited, Lancaster, England
34. Woestenborghs R., Lorreyne W., and Heykants J. J. Chromatogr. Biomed. Appl. 413 (1987) 332-337